HomeCroatian National Cancer Registry
Croatian National Cancer Registry Profile Page
Croatian National Cancer Registry

Contact Info

Department of Epidemiology
Croatian Institute of Public Health
Rockefellerova 7
P.O. Box 684
10 000
Dr. Mario Sekerija


Registration area

The Croatian National Cancer Registry covers the entire population of the Republic of Croatia. Administratively, Croatia is divided into 20 counties and the capital city of Zagreb.

Cancer care facilities

In 2007, the health service entry points were 2552 primary care physicians (general practitioners, gynaecologists, and paediatricians). There were 23 general hospitals, 14 clinical teaching hospitals, and several specialized hospitals, including one dedicated to oncology. Most hospitals in Croatia treat cancer patients, but the main regional oncology centres (offering a full range of services) are located in the clinical hospitals in Zagreb, Split, Osijek, and Rijeka.

Registry structure and methods

The registry is part of the Epidemiology of Chronic Diseases Service at the Croatian National Institute of Public Health (CNIPH) in Zagreb, and is funded by the Croatian Ministry of Health and Social Welfare and the Croatian Health Insurance Fund. The registry’s primary data sources are notifications from hospitals and primary care providers, pathology reports, and mortality databases. Notifications include the name of the health care provider (hospital or physician) that the registry can contact for further information. Electronic hospital discharge records are a supplementary data source. Topography is coded using ICD-10, and morphology is coded using ICD-O-2.

Interpreting the results

An organized population-based screening programme for breast cancer was introduced at the end of 2006, and for colorectal cancer in 2007. Opportunistic screening for cervical cancer has been provided since the 1960s, and the number of Pap tests administered yearly is increasing. Opportunistic screening with the faecal occult blood test is carried out in some regions, and prostate-specific antigen (PSA) testing is becoming more common (although only in patients with urological symptoms).

Use of the data

Cancer incidence data have been presented in an annual report (a bulletin published in Croatian and English) and in the CNIPH’s joint annual report since 1976. Analyses are published in medical journals and postgraduate theses and presented at health congresses and other scientific meetings. Registry data on cancer incidence and mortality are also used for planning and evaluation of preventive measures and various health care services.


This tab contains a basic no-frills image Gallery for CB profiles

No Items published in this profile gallery



Standard Tables

Our partners

120507 01b LOGO X3





This website was developed and is hosted at the International Agency for Research on Cancer (IARC)
Go to top